Steven Shallcross is the founder of Theriva Biologics. He served as lead partner on a transaction with VCN Biosciences in March 2022.
Steven Shallcross is the Chief Executive Officer, Chief Financial Officer, and Director of Theriva Biologics, a clinical-stage biotechnology company developing therapeutics for cancer and related diseases. He served as lead partner on a transaction with VCN Biosciences in March 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library